Physician profile
David A Gerst
NPI 1750491288
$2,105.69
in general payments reported to CMS, 2019-2025
17 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $216 · 2021: $114 · 2022: $392 · 2023: $325 · 2024: $446 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $588.38 | 2019-2023 | Grafix Pl |
| Stryker Corporation | $264.96 | 2023-2025 | Ortholoc 3di, Actishield, Graftjacket |
| Nevro Corp. | $208.56 | 2022-2024 | Senza |
| Celularity INC. | $163.00 | 2019 | |
| Abbott Laboratories | $142.70 | 2023-2025 | Proclaim, Eterna |
| Kerecis Limited | $132.69 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Koya Medical, INC. | $122.55 | 2024 | Dayspring, Koya Medical |
| Organogenesis INC. | $109.55 | 2020-2022 | |
| Orthofix Medical, INC. | $66.87 | 2020 | |
| Paragon 28, INC. | $62.04 | 2024-2025 | Bun-Yo-Matic, Jaws |
| Paratek Pharmaceuticals, INC. | $54.01 | 2024-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $44.48 | 2025 | |
| Horizon Therapeutics Plc | $41.07 | 2022-2023 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $30.15 | 2025 | Exparel |
| Integra Lifesciences Corporation | $27.53 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $24.13 | 2024 | Blastx, Xperience, Surgx |
| Amgen INC. | $23.02 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gerst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.